Background: Gestational diabetes mellitus (GDM) is one of the most common pregnancy disorders; however, if well managed, women with GDM experience similar pregnancy outcomes to those without. Currently, there is limited evidence on actual management practices across Australia or how multidisciplinary teams interact to optimise care. 
INTRODUCTION
Gestational diabetes mellitus (GDM), a condition of maternal hyperglycaemia, is one of the most common pregnancy disorders.
In Australia, around 10% of pregnant women are diagnosed with GDM each year. 1 In 2016-2017, over 37 000 women registered for the National Diabetes Service Scheme with GDM which has doubled since 2012. The maternal and infant consequences of GDM include pre-eclampsia and macrosomia resulting in birth trauma and caesarean deliveries. 2 Longer term, women with GDM are at a seven-fold increased risk of developing type 2 diabetes 3 and offspring are more likely to develop type 2 diabetes later in life. 4 If well managed, women with GDM experience similar pregnancy outcomes to women with normoglycaemia. 5, 6 Despite understanding the risks of GDM, there is no consensus for screening, diagnosis and management among clinical guidelines worldwide. In Australia, health professionals may rely on the Australasian Diabetes in Pregnancy Society (ADIPS) guidelines, 7 state
and local guidelines or professional expertise to guide their treat-
ment. Many states have published guidelines, including Queensland
Health which released its guideline in 2015. 8 This guideline incorporates the World Health Organization (WHO)/ADIPS-endorsed screening and diagnostic recommendations 9 and advise that medical nutrition therapy, self-blood glucose monitoring (SBGM) and physical activity are the primary treatments for GDM. 8 Medication such as insulin may also be required when hyperglycaemia persists, which introduces a greater level of risk, treatment intensity and cost.
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A multidisciplinary team (MDT) consisting of a diabetes educator or nurse practitioner, dietitian and endocrinologist/obstetric physician in addition to obstetricians and midwives should be involved in GDM management. 8, [10] [11] [12] [13] [14] However, it is poorly understood how the MDT interact to optimise treatment for women, or the most efficient way to produce effective results. Recent changes to the diagnostic criteria in Australia may increase the GDM workload by 20-30%, 15, 16 with a recent study demonstrating a 30% increase. 17 Therefore, it is important to develop models of care that allow women with GDM access to specialist care within the finite healthcare budget.
First, it is important to understand how care is currently organised in Australia, how health professionals perceive their roles and others', and barriers and enablers to implementing changes to practice. There is limited Australian literature investigating the management practices for GDM, and no Australian studies have examined healthcare professionals' perceptions of GDM management tasks or MDT member roles. Therefore, the aim of this study was to examine the current screening, diagnostic and management practices, and task and role perceptions as reported by members of the GDM MDT.
MATERIALS AND METHODS

Study design and participants
This was a cross-sectional study using snowball and purposive sampling of all members of the MDT involved in GDM management across Australia. An online survey using Survey Monkey ® with a letter of invitation was disseminated via the professional organisations: and South Australia (2%). The demographic profile of survey respondents is shown in Table 1 .
Screening and diagnosis of GDM
Ninety-four percent of respondents stated that all women were screened for GDM (universal screening). Almost 90% of respondents reported using the WHO/ADIPS criteria for the diagnosis of GDM and the same number used the 75 g oral glucose tolerance test (OGTT).
Management of GDM
Sixty-three percent used guidelines for the management of women with GDM and an additional 21% reported that guidelines were available at their health service, but they used their professional expertise to manage GDM. Eight percent of respondents stated their workplace did not have guidelines. Women were usually seen for initial education within 1-2 weeks (55%) or <1 week (41%) with face-to-face contact used 98% of the time. Group education was used most frequently for initial education (53%);
however, around 40% reported seeing women for an individual appointment. The health professional(s) responsible for the various tasks involved in managing GDM and appointment frequency are outlined in Table 2 .
The initial approach for managing GDM involved SBGM (98%), medical nutrition therapy provided by a dietitian (82%), physical activity (79%) and gestational weight gain advice (72%).
Diet advice provided by any healthcare professional was reported by 34% while commencement of pharmacotherapy may be used as a first-line approach according to 22% of respondents. Factors that warranted ongoing dietary advice included unstable blood glucose levels (BGLs) (93%), excess gestational weight gain (85%), weight loss (82%), or concerns from a health professional (82%) or patient (69%) about nutrient deficiencies.
Seventy-six percent reported that gestational weight gain was tracked throughout pregnancy. Eighty-five percent of respondents indicated that women are advised to undertake a postpartum OGTT with their GP, while 24%
reported that this was done at the hospital. Almost 60% of respondents indicated that women were advised to optimise postpartum 
Percentage of respondents
Employment sector
Public hospital with specialised diabetes in pregnancy services
56
Public hospital without specialised diabetes in pregnancy services 17
Public diabetes centre 4
Private hospital 3
Private practice 10
Community health centre 10
Geographic location
Metropolitan 51
Regional 30
Remote 19
Years in profession and interpregnancy weight, 71% provided dietary or other lifestyle advice, while 57% advised on breastfeeding.
Role perceptions and attitudes about management principles
The level of agreement for each of the 15 tasks according to respondents is shown in Table 3 . Most respondents agreed that: a MDT approach is best; women should be given advice on physical activity, SBGM and gestational weight gain; blood glucose monitoring records should be checked at follow-up appointments; and women who do not achieve optimal BGLs should receive pharmacotherapy (Table 3 ). There was less agreement on tasks such as routine and repeat ultrasounds to monitor fetal growth, advice on the antenatal expression of milk, and urine testing for the presence of protein or ketones (Table 3 ).
For many of the tasks, it appeared some were clearly considered the responsibility of certain health professionals (Fig. 1 ).
Medical nutrition therapy was the domain of the dietitian, fetal growth monitoring via ultrasound scan the obstetrician, commencing pharmacotherapy the endocrinologist and SBGM education the diabetes educator (Fig. 1) . For other tasks it was less clear and 60-70% of respondents felt that these many tasks could be performed by any MDT member (Fig. 1) . 83% (139) 16% (26) 14% (24) 23% (39) 6% (10) Follow up
Other tasks or requirements in GDM management as indi-
154
71% (109) 69% (107) 36% (56) 49% (76) 46% (71) 9% (14) 13% (20) Frequency of follow-up appointments
129
Weekly 34% (37)
17% (18) 1% (1) 5% (5) 7% (6) 2% (1) Fortnightly 36% (40) 29% (31) 29% (24) 44% (42) 51% (46) 8% (5) Monthly 8% (9) 21% (22) 23% (19) 23% (22) 12% (11) 7% (4) Unsure 15% (16) 21% (22) 24% (20) 17% (16) 20% (18) 46% (28) Not applicable 7% (8) 12% (13) 22% (18) 11% (10) 10% (9) 38% (23) Health professional responsible for ongoing review of BGLs
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78% (120) 31% (48) 41% (63) 41% (63) 37% (56) 10% (16) 14% (22) GDM managed through diet -health care professional responsible for ongoing management
56% (86) 38% (58) 18% (27) 51% (78) 46% (71) 12% (18) 11% (17) Health professional responsible for identifying women who require additional intervention
154
79% (121) 46% (71) 40% (62) 48% (74) 35% (54) 12% (19) 8% (12) BGL, blood glucose level; GDM, gestational diabetes mellitus; GP, general practitioner.
also recommended an OGTT 6-12 weeks postpartum to screen for type 2 diabetes, although actual rates of follow up are typically low. 22 In Australia, women who are registered with the National Gestational Diabetes Register receive postal reminders which appears to have improved compliance to postpartum testing in recent years. 23 Australia and New Zealand guidelines recommend lifelong type 2 diabetes screening and testing alternatives to the two-hour OGTT, such as glycosylated haemoglobin (Hba1C) and random plasma blood glucose, may be appropriate and more acceptable to women. 7, 14 Blood glucose targets remain an area of controversy, with the ADIPS guidelines acknowledging this is an area requiring further research. 7 This is reflected by the variation in targets reported in this survey. BGLs should only form part of the picture when deciding whether pharmacotherapy should be commenced, and fetal growth should be considered when setting blood glucose targets. 8, 24 International and Australian recommendations include monitoring fetal response to GDM by way of repeat ultrasounds every 2-4 weeks in the second and third trimesters. 8, 25 Particular attention should be paid to the accurate measurement of fetal abdominal circumference 8, 25 and altering BGL targets based on normal or accelerated fetal growth may improve infant outcomes. 24 While three-quarters of respondents of this survey agreed that BGLs should be considered alongside fetal growth and maternal weight gain, almost 100% agreed that BGLs were the best indicator of whether a woman should receive pharmacotherapy. This inconsistency highlights the need for ongoing research translation of best available evidence. Addressing this evidence-practice gap will help inform stratification of care based on high and low risk cases, and there may be a case for BGL targets that reflect women's specific circumstances.
The initial approach to managing GDM involves medical nutrition therapy, SBGM and physical activity advice. 8, 25, 26 However, 20% of respondents reported that medical nutrition therapy and physical activity advice were not part of the initial approach at their workplace. The same number of respondents indicated that a dietitian is not involved in initial education, similar to results reported by Morrison et al. (2011) . 19 Of concern, almost one-quarter of our respondents indicated that pharmacotherapy may be used Women who do not achieve optimal BGLs with lifestyle modification should receive pharmacotherapy 97 2 1
Women should be given advice on what is and how to achieve appropriate gestational weight gain based on their pre-pregnancy body mass index
4 1
Women should be assessed for risk factors associated with GDM at the first antenatal visit
Women should have their gestational weight gain tracked at follow-up appointments 93 5 2
Medical nutrition therapy should be the first-line treatment in GDM 90 7 3
BGLs are the best indicator of whether a woman with GDM should commence pharmacotherapy 82 13 5
BGLs should always be considered alongside fetal growth and maternal weight gain before deciding whether a woman with GDM should commence pharmacotherapy 75
10
Women should have repeat ultrasounds to monitor fetal growth 74 21 5
Women should undertake a routine ultrasound to establish a baseline for future evaluation of fetal growth
Women should have their urine tested at one or more follow-up appointments for the presence of protein 61 29 10
Women should be given advice on the antenatal expression of milk 57 38 5
Women should have their urine tested at one or more follow-up appointments for the presence of ketones 43 37 20
Only women with BGLs outside of recommended targets should be provided with ongoing medical nutrition therapy 28 12 60
BGL, blood glucose level; GDM, gestational diabetes mellitus; MDT, multidisciplinary team.
as a first-line approach in managing GDM and one-third indicated that diet advice may be provided by anyone in the MDT, inconsistent with current evidence.
5,6,25
Task and role perceptions as reported here indicated that certain tasks are considered the responsibility of specific MDT members, whereas others can be performed by almost any MDT member. For example, medical nutrition therapy and gestational weight gain advice is considered the domain of the dietitian, although half of the respondents also considered these tasks could also be undertaken by a diabetes educator with no specialist nutrition training. It is concerning that in 10 years there appears to be no increase in dietetic services for GDM in Australian with 20%
of women still not accessing a dietitian.
19
Tasks such as commencing pharmacotherapy or ultrasound fetal measurements were predominately considered the domain of medical specialists, while SBGM education fell under the role of the diabetes educator. However, checking of blood glucose records was considered anyone's task, as were most other tasks in this survey. As the authors were unable to identify any similar surveys on task and role perception in GDM management, it is difficult to ascertain whether this lack of role identity for tasks is unique to Australian GDM management. Our results may also highlight that specialist skills in certain regions are lacking considering that almost 20% of respondents were from rural or remote facilities.
To the best of our knowledge, this study represents the most comprehensive survey of a diverse range of members of the GDM multidisciplinary team on the management of GDM in Australia.
A strength of the study is the breadth of respondents' professions and the reported level of adherence to current Australian guidelines. However, there were several limitations to our study. 
CONCLUSION
Overall, the results of this survey highlight considerable variation in how GDM is managed across Australia and demonstrates a need for further evidence in managing GDM. By understanding current practices, health services can begin to develop new models of care that can improve efficiencies, costs and patient care, given the predicted (and actual) workload increases in recent years. There is a real need to integrate new evidence into clinical guidelines and ensure that knowledge is translated into practice so that consistent care is provided across all regions and health services in Australia.
F I G U R E 1
Percentage of survey respondents who indicated which health professional can undertake each task. *Additional health professionals included in the answer options. DE/CDE, diabetes educator/credentialed diabetes educator; GWG, gestational weight gain; MNT, medical nutrition therapy; SBGM, self-blood glucose monitoring; USS, ultrasound.
